Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
01/2011
01/19/2011EP2275403A1 Process for phenylacetic acid derivatives
01/19/2011EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds
01/19/2011EP2274278A1 New process for the preparatiion of cyclohexanecarboxylic acid dericatives
01/19/2011EP2274276A2 Process for the manufacture of memantine and intermediate product
01/19/2011EP2274274A1 Continuous method for producing fatty acid amides
01/19/2011EP2274273A1 Continuous method for producing amides of ethylenically unsaturated carboxylic acids
01/19/2011EP2274272A1 Continuous method for producing fatty acid alkanol amides
01/19/2011EP2274271A1 Method for producing amides in the presence of superheated water
01/19/2011EP2274270A1 Continuous method for producing amides of low aliphatic carboxylic acids
01/19/2011EP2274269A1 Continuous method for producing amides of aromatic carboxylic acids
01/19/2011EP2274264A1 New process for the preparation of cyclohexanecarboxylic acid derivatives via the corresponding cyclohexanecarboxamide derivative
01/19/2011CN101952243A 4-dimethylaminobutyric acid derivatives
01/19/2011CN101952234A Phenyl-prenyl derivatives, of marine and synthetic origin, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
01/19/2011CN101948401A Synthesis method of N,N-dicyclohexyl terephthalamide
01/19/2011CN101948374A Method for synthesizing alpha-bromoketone and coproducing bromohydrocarbon
01/19/2011CN101507917B Solid base catalyst for synthesizing alkanolamide type compound and preparation method thereof
01/19/2011CN101260065B Method for separating high-pure capsicine monomer from capsicines compounds
01/18/2011US7872154 Reacting 2-halo-1-(4-fluorophenyl)-2-phenone of formula II with 4-methyl-3-oxo-N-phenylpentamide; high purity and good yield; for the synthesis of atorvastatin
01/18/2011US7872153 Aliskiren hydrogen sulfate; crystal forms which are stable and easier to manage in the drying, filtration or granulation processes; used in conjuction with HMG-Co-A reductase inhibitor; angiotensin converting enzyme; calcium channel blocker; aldosterone synthase inhibitors; aldosterone antagonists
01/18/2011US7872152 Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
01/18/2011US7872151 Inhibitors of α4 mediated cell adhesion
01/18/2011US7872026 retinoic acid receptor (RAR) activators such as 4'-(4-Isopropylaminobutoxy)-3'-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphth-2-yl)biphenyl-4-carboxylic acid, suited for administration in human or veterinary medicine; dermatology
01/18/2011US7871635 comprising a cosmetically acceptable medium and a compound N-( omega -undecylenoyl) phenylalanine; inactivates adenylate cyclase and has an affinity for the melocytic specific hormone ( alpha -MSH)
01/13/2011WO2010117598A3 Hydrophobic monomers, hydrophobically-derivatized supports, and methods of making and using the same
01/13/2011US20110009641 Amine-containing lipids and uses thereof
01/13/2011US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
01/13/2011US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis
01/13/2011US20110008498 Methods and Compositions for Preparing Consumables with Optical Shifting Properties
01/12/2011EP2272822A1 Inhibitor of plasminogen activator inhibitor-1
01/12/2011EP2272817A1 Pai-1 inhibitor
01/12/2011EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds
01/12/2011EP2271614A2 Method for the continuous synthesis of an n-acylated compound, and equipment for implementing said method
01/12/2011EP1478619B1 A process for preparing a phenylalanine derivative and intermediates thereof
01/12/2011CN1826098B Production of small particles
01/12/2011CN101945697A Thermoplastic composition
01/12/2011CN101941916A Method for refining high-purity N, N-diethyl-3-methylbenzamide
01/12/2011CN101175777B (methyl)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and method for forming pattern
01/11/2011US7868206 2-amino-N-benzyl-4-(trifluoromethylthio)butanamide, used for the treatment or prevention of infectious diseases caused by protozoa or bacterium; therapeutic drugs for entamebiasis or trichomoniasis
01/11/2011US7868205 N-[2-amino-5-(2-thienyl)phenyl]-4-{[(3,4-dimethoxyphenyl)amino]methyl}benzamide; antiproliferative, antiprotozoal agent; lymphoma, lung cancer, colon cancer, prostrate cancer, stomach cancer, breast cancer, leukemia
01/11/2011US7868204 Inhibitors of histone deacetylase
01/11/2011CA2411283C Chiral monophosphites as ligands for asymetrical synthesis
01/11/2011CA2400486C Aniline-derived ligands for the thyroid receptor
01/11/2011CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors
01/06/2011WO2011003061A2 Production of tran s-4-aminocyclopent-2-ene-1-carboxylic acid derivatives
01/06/2011WO2011002339A2 PHARMACEUTICALLY ACCEPTABLE SALTS OF (S)-N-[4-(1-ADAMANTYL)BENZOYL-α-AMINO ACIDS AND METHOD FOR THE PRODUCTION THEREOF
01/06/2011WO2011000537A1 Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane
01/06/2011WO2011000459A1 Continuous method for producing amides of aromatic carboxylic acids
01/06/2011US20110004020 Process for producing organic carboxylic acid amides
01/06/2011US20110004019 Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same
01/06/2011US20110004014 Catalytic Depolymerization of Polymers Containing Electrophilic Linkages Using Nucleophilic Reagents
01/06/2011US20110003852 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
01/06/2011US20110003784 Opsin-binding ligands, compositions and methods of use
01/06/2011CA2766950A1 Device for continuously carrying out chemical reactions at high temperatures
01/06/2011CA2766933A1 Continuous method for acylating amino group-carrying organic acids
01/06/2011CA2766926A1 Continuous method for producing amides of aromatic carboxylic acids
01/06/2011CA2765743A1 Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane
01/05/2011EP2268616A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
01/05/2011EP2268606A1 4-dimethylaminobutyric acid derivatives
01/05/2011EP2268605A1 Fatty acid derivatives for oral administration endowed with high paia- tability
01/05/2011EP2268603A1 Process for the preparation of 2-amino-2- [2- (4-c3-c21-alkyl-phenyl)ethyl]propane-1, 3-diols
01/05/2011EP1517880B1 Production of cis-pellitorin and use as a flavouring
01/05/2011DE102009031057A1 Kontinuierliches Verfahren zur Herstellung von Amiden aliphatischer Carbonsäuren A continuous process for the preparation of amides of aliphatic carboxylic acids
01/05/2011CN201692752U DMF gas recovery device
01/05/2011CN101939288A Difluorobiphenylamide derivatives for the treatment of ocular hypertension
01/04/2011US7863484 Eliminating the impurities of ABA monomethylester and of ABA dimer contained in an aqueous solution of 5-amino-N,N'-bis(2,3-dihydroxypropyl)-isophthalamide (ABA) or ABA hydrochloride by hydrolyzing them at a pH of 12-13 using sodium hydroxide; x-ray contrast agents, ioversol, iodixanol, iohexol
01/04/2011US7863478 UV filters
01/04/2011US7863475 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active
01/04/2011US7863333 asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis; Azetidine-1-carboxylic acid {2-[({2-hydroxy-1-[(isopropyl-methyl-amino)-methyl]-pentylcarbamoyl}-methyl)-carbamoyl]-4-trifluoromethyl-phenyl}-amide
01/04/2011CA2371048C Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid
01/04/2011CA2319672C Compounds and compositions for delivering active agents
12/2010
12/30/2010US20100331575 Processes For The Preparation Of Optically Active Intermediates
12/30/2010US20100331566 Synthetic methods and compositions
12/30/2010US20100331413 Therapeutic Formulations Based on Asiatic Acid and Selected Salts Thereof
12/30/2010US20100331383 Compounds for the treatment of aids and other viral diseases
12/29/2010WO2010151489A1 Purification of tertiary formamide contaminated with tertiary acetamide
12/29/2010WO2010150816A1 Composition, compound and membrane formation method
12/29/2010WO2010150564A1 Benzaldehyde compound
12/29/2010WO2010149760A2 Mexiletine amino acid and peptide prodrugs and uses thereof
12/29/2010EP2266949A1 "Fast, high-efficiency quantitative synthesis of paracetamol"
12/29/2010EP2266577A1 Multi-substitued selective androgen receptor modulators and methods of use therof
12/29/2010EP2266552A2 Methods of inducing terminal differentiation
12/29/2010EP2265373A2 Hydrogenation of imines
12/29/2010EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/29/2010CN1898194B New process for the synthesis of eneamide derivatives
12/29/2010CN101932553A Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds
12/29/2010CN101928280A Pepperphentonamine derivative containing naphthalene rings
12/29/2010CN101928274A Peperphentonamine derivative
12/29/2010CN101928233A Cholromethylation method of benzoic acid derivative
12/29/2010CN101928225A Method for preparing N,N,N',N'-tetrakis(2-hydroxyethyl)adipamide
12/29/2010CN101928213A Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom
12/29/2010CA2765462A1 Mexiletine amino acid and peptide prodrugs and uses thereof
12/28/2010US7858787 Carbon addition; diphosphine diamido cobalt catalyic hydroformylation of olefin with carbon monoxide and hydrogen then dehydrating; economical; high linearity alpha-olefin production; copolymerization monomers
12/23/2010WO2010145992A1 Herbicidal benzoxazinones
12/23/2010WO2010088450A3 Arylamide derivatives useful in the treatment of diseases associated with serca activity
12/23/2010US20100324313 Method for the purification of prostaglandins
12/23/2010US20100324159 Novel ion exchange porous resins for solid phase extraction and chromatography
12/23/2010US20100324130 Daa peripheral benzodiazepine receptor ligand for cancer imaging and treatment
12/23/2010US20100324025 Antibacterial Agents
12/23/2010US20100324000 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptors
12/23/2010CA2763938A1 Herbicidal benzoxazinones
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 289